DrugDashboards

PureVit DualFe Plus

Ferrous Fumarate, Polysaccharide Iron Complex · CUPRIC SULFATE .8 mg/1; FERROUS FUMARATE 53 mg/1; IRON DEXTRAN 53 mg/1; RIBOFLAVIN 6 mg/1; NIACINAMIDE 30 mg/1; PYRIDOXINE HYDROCHLORIDE 5 mg/1; FOLIC ACID 1 mg/1; CYANOCOBALAMIN 15 ug/1; CALCIUM PANTOTHENATE 10 mg/1; SODIUM ASCORBATE 200 mg/1; THIAMINE MONONITRATE 10 mg/1; ZINC SULFATE 18.2 mg/1; MANGANESE SULFATE 1.3 mg/1 · Capsule · Oral · PureTek Corporation

NDC 59088-0112-66 · 90 CAPSULE in 1 BOTTLE, PLASTIC · UNAPPROVED DRUG OTHER · View full market →

The short version

Only one company currently supplies this market — there is no backup if it stumbles. The price has held steady around $0.3839 per unit over the past year. Put together: worth watching — several of the pressures that precede supply trouble are present at once.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.25$0.5$0.75Oct 2013Sep 2026$0.3839
59 price points · per EASource: CMS NADAC

Estimated fill cost

#30 count
$11.52
#90 count
$34.55

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Supply fragility

30Elevated risk

The score is counting real pressure here. One of these alone is routine; it’s the combination that makes this market worth watching.

  • 1 active manufacturer+30

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.0%chance of a new FDA shortage posting for ferrous fumarate, polysaccharide iron complex (oral solid) in the next 90 days

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
TE code
Approval date
Patents / exclusivity

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ferrous Fumarate, Polysaccharide Iron Complex (Capsule)

LabelerStrengthFirst seenLast seen
PureTek CorporationCUPRIC SULFATE .8 mg/1; FERROUS FUMARATE 53 mg/1; IRON DEXTRAN 53 mg/1; RIBOFLAVIN 6 mg/1; NIACINAMIDE 30 mg/1; PYRIDOXINE HYDROCHLORIDE 5 mg/1; FOLIC ACID 1 mg/1; CYANOCOBALAMIN 15 ug/1; CALCIUM PANTOTHENATE 10 mg/1; SODIUM ASCORBATE 200 mg/1; THIAMINE MONONITRATE 10 mg/1; ZINC SULFATE 18.2 mg/1; MANGANESE SULFATE 1.3 mg/1Aug 26, 2026Sep 2, 2026
PureTek CorporationCUPRIC SULFATE 10 mg/1; FERROUS FUMARATE .8 mg/1; IRON DEXTRAN 15 ug/1; RIBOFLAVIN 53 mg/1; NIACINAMIDE 1 mg/1; PYRIDOXINE HYDROCHLORIDE 53 mg/1; FOLIC ACID 1.3 mg/1; CYANOCOBALAMIN 30 mg/1; CALCIUM PANTOTHENATE 5 mg/1; SODIUM ASCORBATE 6 mg/1; THIAMINE MONONITRATE 200 mg/1; ZINC SULFATE 10 mg/1; MANGANESE SULFATE 18.2 mg/1Jul 22, 2026Aug 19, 2026
PureTek CorporationCALCIUM PANTOTHENATE 10 mg/1; CUPRIC SULFATE .8 mg/1; CYANOCOBALAMIN 15 ug/1; FERROUS FUMARATE 53 mg/1; FOLIC ACID 1 mg/1; IRON DEXTRAN 53 mg/1; MANGANESE SULFATE 1.3 mg/1; NIACINAMIDE 30 mg/1; PYRIDOXINE HYDROCHLORIDE 5 mg/1; RIBOFLAVIN 6 mg/1; SODIUM ASCORBATE 200 mg/1; THIAMINE MONONITRATE 10 mg/1; ZINC SULFATE 18.2 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "PureVit DualFe Plus — NDC 59088-0112-66," retrieved September 3, 2026, https://drugdashboards.com/drug/59088011266.

Free to cite with attribution — see how the data is put together.